Worldwide Bloodstream Infection Testing Industry to 2024 - Key Drivers, Challenges and Trends

Research and Markets
·4-min read

Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Bloodstream Infection Testing Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The publisher has been monitoring the bloodstream infection testing market and it is poised to grow by USD 691.32 million during 2020-2024, progressing at a CAGR of 9% during the forecast period. The reports on the bloodstream infection testing market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing hospital visits, unmet needs in developing countries, and growing government regulations increasing blood donation awareness.

The bloodstream infection testing market analysis includes technology segment and geographical landscapes. This study identifies the increased adoption of automation in healthcare as one of the prime reasons driving the bloodstream infection testing market growth during the next few years. Also, increasing demand for infection control committees in hospitals and the increasing number of blood donors will lead to sizable demand in the market.

The bloodstream infection testing market report covers the following areas:

  • Bloodstream infection testing market sizing

  • Bloodstream infection testing market forecast

  • Bloodstream infection testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bloodstream infection testing market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the bloodstream infection testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

3. Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

5. Market Segmentation by Technology

  • Market segments

  • Comparison by Technology

  • Conventional testing - Market size and forecast 2019-2024

  • Non-conventional testing - Market size and forecast 2019-2024

  • Market opportunity by Technology

6. Customer landscape

  • Customer landscape

7. Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

8. Vendor Landscape

  • Vendor landscape

  • Landscape disruption

  • Competitive Scenario

9. Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Abbott Laboratories

  • Accelerate Diagnostics Inc.

  • bioMerieux SA

  • Bruker Corp.

  • Danaher Corp.

  • F. Hoffmann-La Roche Ltd.

  • Grifols SA

  • Siemens Healthineers AG

  • Thermo Fisher Scientific Inc.

10. Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/vcrswk

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900